Compare ADUS & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ADUS | PAHC |
|---|---|---|
| Founded | 1979 | 1946 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.6B |
| IPO Year | 2009 | 2014 |
| Metric | ADUS | PAHC |
|---|---|---|
| Price | $110.12 | $39.38 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 10 | 4 |
| Target Price | ★ $138.40 | $31.25 |
| AVG Volume (30 Days) | 150.4K | ★ 243.8K |
| Earning Date | 02-23-2026 | 02-04-2026 |
| Dividend Yield | N/A | ★ 1.22% |
| EPS Growth | 6.76 | ★ 288.74 |
| EPS | ★ 4.66 | 1.67 |
| Revenue | $1,346,596,000.00 | ★ $1,399,676,000.00 |
| Revenue This Year | $25.50 | $15.34 |
| Revenue Next Year | $7.11 | $3.28 |
| P/E Ratio | ★ $23.54 | $23.61 |
| Revenue Growth | 18.77 | ★ 33.72 |
| 52 Week Low | $88.96 | $16.16 |
| 52 Week High | $136.72 | $46.42 |
| Indicator | ADUS | PAHC |
|---|---|---|
| Relative Strength Index (RSI) | 44.72 | 49.96 |
| Support Level | $105.21 | $38.00 |
| Resistance Level | $113.94 | $40.43 |
| Average True Range (ATR) | 2.71 | 1.48 |
| MACD | 0.21 | 0.28 |
| Stochastic Oscillator | 55.67 | 74.36 |
Addus HomeCare Corp is engaged in the provision of in-home personal care services. It operates through the segments such as Personal care segment, which is a key revenue driver, provides non-medical assistance with activities of daily living, mainly to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. The Hospice segment provides physical, emotional and spiritual care for people who are terminally ill and their families. Its Home health segment provides services that are medical in nature to those individuals who may require assistance during an illness or after surgery.
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.